103 related articles for article (PubMed ID: 12210779)
1. Synthesis and multidrug-resistance modulating activity of a series of thienothiazines.
Chiba P; Erker T; Galanski M; Hitzler M; Ecker GF
Arch Pharm (Weinheim); 2002 May; 335(5):223-8. PubMed ID: 12210779
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines.
Hiessböck R; Wolf C; Richter E; Hitzler M; Chiba P; Kratzel M; Ecker G
J Med Chem; 1999 Jun; 42(11):1921-6. PubMed ID: 10354400
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.
Chiba P; Ecker G; Schmid D; Drach J; Tell B; Goldenberg S; Gekeler V
Mol Pharmacol; 1996 Jun; 49(6):1122-30. PubMed ID: 8649352
[TBL] [Abstract][Full Text] [Related]
4. 6,12-dihydro-1-benzopyrano[3,4-b][1,4]benzothiazin-6-ones: synthesis and mdr reversal in tumor cells.
Shah A; Naliapara Y; Sureja D; Motohashi N; Kawase M; Miskolci C; Szabo D; Molnár J
Anticancer Res; 1998; 18(4C):3001-4. PubMed ID: 9713499
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity-relationship studies on modulators of the multidrug transporter P-glycoprotein--an overview.
Ecker G; Chiba P
Wien Klin Wochenschr; 1995; 107(22):681-6. PubMed ID: 8533428
[TBL] [Abstract][Full Text] [Related]
6. Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships.
Ferté J; Kühnel JM; Chapuis G; Rolland Y; Lewin G; Schwaller MA
J Med Chem; 1999 Feb; 42(3):478-89. PubMed ID: 9986718
[TBL] [Abstract][Full Text] [Related]
7. Substituted 4-acylpyrazoles and 4-acylpyrazolones: synthesis and multidrug resistance-modulating activity.
Chiba P; Holzer W; Landau M; Bechmann G; Lorenz K; Plagens B; Hitzler M; Richter E; Ecker G
J Med Chem; 1998 Oct; 41(21):4001-11. PubMed ID: 9767638
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range.
Teodori E; Dei S; Quidu P; Budriesi R; Chiarini A; Garnier-Suillerot A; Gualtieri F; Manetti D; Romanelli MN; Scapecchi S
J Med Chem; 1999 May; 42(10):1687-97. PubMed ID: 10346921
[TBL] [Abstract][Full Text] [Related]
9. Halogenated chalcones with high-affinity binding to P-glycoprotein: potential modulators of multidrug resistance.
Bois F; Beney C; Boumendjel A; Mariotte AM; Conseil G; Di Pietro A
J Med Chem; 1998 Oct; 41(21):4161-4. PubMed ID: 9767651
[TBL] [Abstract][Full Text] [Related]
10. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
Gopinath VS; Thimmaiah P; Thimmaiah KN
Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
[TBL] [Abstract][Full Text] [Related]
11. Benzo[b]-1,8-naphthyridine derivatives: synthesis and reversal activity on multidrug resistance.
Misbahi H; Brouant P; Hevér A; Molnár AM; Wolfard K; Spengler G; Mefetah H; Molnár J; Barbe J
Anticancer Res; 2002; 22(4):2097-101. PubMed ID: 12174889
[TBL] [Abstract][Full Text] [Related]
12. New 1,3-dioxolane and 1,3-dioxane derivatives as effective modulators to overcome multidrug resistance.
Schmidt M; Ungvári J; Glöde J; Dobner B; Langner A
Bioorg Med Chem; 2007 Mar; 15(6):2283-97. PubMed ID: 17276076
[TBL] [Abstract][Full Text] [Related]
13. The importance of a nitrogen atom in modulators of multidrug resistance.
Ecker G; Huber M; Schmid D; Chiba P
Mol Pharmacol; 1999 Oct; 56(4):791-6. PubMed ID: 10496963
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance reversal activity of permethyl ningalin B amide derivatives.
Tao H; Hwang I; Boger DL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5979-81. PubMed ID: 15546712
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms.
Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W
Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.
Lee BD; Li Z; French KJ; Zhuang Y; Xia Z; Smith CD
J Med Chem; 2004 Mar; 47(6):1413-22. PubMed ID: 14998330
[TBL] [Abstract][Full Text] [Related]
17. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells.
Chan KF; Zhao Y; Burkett BA; Wong IL; Chow LM; Chan TH
J Med Chem; 2006 Nov; 49(23):6742-59. PubMed ID: 17154505
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors.
Voigt B; Coburger C; Monár J; Hilgeroth A
Bioorg Med Chem; 2007 Aug; 15(15):5110-3. PubMed ID: 17533131
[TBL] [Abstract][Full Text] [Related]
20. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.
Majumder S; Dutta P; Mukherjee P; Datta ER; Efferth T; Bhattacharya S; Choudhuri SK
Cancer Lett; 2006 Nov; 244(1):16-23. PubMed ID: 16410038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
